Publications by authors named "Jason Cota"

Claim this Profile
P
Post-pandemic trends in Streptococcus pneumoniae serotype epidemiology and antibiotic susceptibility in adults with invasive and non-invasive pneumococcal disease in the USA (2022-2023).
Mekki F Bensaci, Karri A Bauer, Kenneth Klinker, Jason Cota, Rodrigo E Mendes

J Antimicrob Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
Jason M Cota, Taylor M Benavides, John D Fields, Nathan Jansen, Anuradha Ganesan

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critically Ill Recipients of Weight-Based Fluconazole Meeting Drug-Induced Liver Injury Network Criteria.
Merlyn Joseph, Rebecca Brady, Russell Attridge, Jason Cota, Cheryl Horlen

Hosp Pharm· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections.
Hansita B Patel, Kathleen A Lusk, Jason M Cota

J Pharm Pract· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
Jason M Cota, Alireza FakhriRavari, Matthew P Rowan, Kevin K Chung, Clinton K Murray

Clin Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.
Kevin S Akers, Matthew P Rowan, Krista L Niece, Ian J Stewart, Katrin Mende, Jason M Cota

Antimicrob Agents Chemother· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
Kevin S Akers, Krista L Niece, Kevin K Chung, Jeremy W Cannon, Jason M Cota

J Trauma Acute Care Surg· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Kevin S Akers, Jason M Cota, Kevin K Chung, Evan M Renz, Katrin Mende

J Burn Care Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration.
Kevin S Akers, Jason M Cota, Christopher R Frei, Kevin K Chung, Katrin Mende

Antimicrob Agents Chemother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis.
Nathan P Wiederhold, Jason M Cota, Christopher R Frei

Infect Drug Resist· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin.
Jason M Cota, Jodi L Grabinski, Robert L Talbert, David S Burgess, P David Rogers

Antimicrob Agents Chemother· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
Jason Cota, Michael Carden, John R Graybill, Laura K Najvar, David S Burgess

Antimicrob Agents Chemother· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis